Therachon Appoints Biotechnology Leader As Chief Medical Officer Post author:Sam Post published:August 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>ISPE</b> Releases The New Cultural Excellence Report May 7, 2017 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 DBV Technologies Crashed as Allergy Drug Flunked Phase III Test October 22, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017